Helicore Biopharma

Helicore Bio — Long-Acting Medicines to Transform Metabolic Health

Helicore Biopharma was founded in 2025, is headquartered in South San Francisco, United States, lists 1–10 employees, and has $65.0M in recorded funding across 1 round.

Employees
1–10
Founded
2025
Business Model
B2B
Total Funding
$65.0M
Last Round
$65.0M Series AJan 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Helicore Bio is developing long-acting therapies in obesity and cardiometabolic disease using a proprietary antibody-peptide conjugate platform. The company has developed proprietary libraries of GLP-1R agonist and amylin receptor agonist therapeutic peptides, optimized for bias, selectivity, and potency. Its conjugate pipeline is anchored by a proprietary GIP ligand binder antibody that demonstrated safety, tolerability, and target engagement in a Phase 1 study. Helicore programs combine that antibody backbone with distinct proprietary peptide payloads, targeting different patient populations and indications from a single modular platform.

Summary

Helicore Biopharma is a Biotech company based in South San Francisco, United States, founded in 2025. It lists 1–10 employees. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Jan 2025. Investors include Versant Ventures, OrbiMed and Longitude Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2025
$65.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Helicore Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/helicore-biopharma"><img src="https://indexed.vc/api/badge/company/helicore-biopharma" alt="Helicore Biopharma on Indexed.vc" width="260" height="76" /></a>